-
NMPA Issued the Notice on Strengthening the Supervision and Inspection of Sterile and Implantable Medical Devices
2020-04-14
On April 14, 2020, NMPA issued the Notice on Strengthening the Supervision and Inspection of Sterile and Implantable Medical Devices.
-
NMPA Issued the Announcement on the Guidance for Medical Device Registrants to Conduct Adverse Events Monitoring
2020-04-10
NMPA has organized the formulation of and released on April 10, 2020 the Guidance for Medical Device Registrants to Conduct Adverse Events Monitoring.
-
NMPA Issued the Announcement on Issues Pertaining to the Current Administration on Drug Distribution
2020-04-03
On April 3, 2020, NMPA issued the Announcement on Issues Pertaining to the Current Administration on Drug Distribution.
-
NMPA Issued the Announcement on Issues Pertaining to the Implementation of the Newly Revised Provisions for the Supervision and Administration of Drug Production
2020-03-31
On March 31, 2020, NMPA issued the Announcement on Issues Pertaining to the Implementation of the Newly Revised Provisions for the Supervision and Administration of Drug Production (No. 47 of 2020).
-
NMPA Announcement on Issues Pertaining to the Implementation of the Provisions for Drug Registration
2020-03-31
On March 31, 2020, NMPA issued the Announcement on Issues Pertaining to the Implementation of the Provisions for Drug Registration (No. 46 of 2020).
-
SAMR Promulgates the Provisions for Drug Registration and Provisions for the Supervision and Administration of Drug Production
2020-03-30
On March 30, the State Administration for Market Regulation (SAMR) promulgated the Provisions for Drug Registration by Order No. 27, and the Provisions for the Supervision and Administration of Drug Production by Order No. 28, which shall be officially implemented from July 1, 2020.